Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health In Schools topic
No spam. Unsubscribe anytime.
Committee approves language change to allow any FDA‑approved opioid overdose reversal medication in schools
Summary
A bill amending school code to permit school stock of any Food and Drug Administration–approved opioid overdose reversal medication — not just naloxone — drew brief explanation and support from the sponsor.
The committee heard a brief explanation of House Bill 13‑76, which would amend the statutory definition of emergency medication that schools may keep on‑site to allow any Food and Drug Administration‑approved opioid overdose reversal medication, including nasal sprays, rather than listing naloxone by name.
The bill’s sponsor noted the rise in illicit fentanyl and the availability of additional reversal agents such as nalmefene. Witnesses and the sponsor said the change simply expands permissible options and does not mandate stocking or create a fiscal obligation for school corporations.
No public opposition was recorded in the hearing. Committee members had no substantive questions and the measure moved forward without debate at this meeting.
